Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Pembrolizumab, Ibrutinib and Rituximab in PCNSL

Dana-Farber Cancer Institute · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
primary central nervous system lymphoma, recurrent cancer, refractory cancer, relapsed cancer, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 911197
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.